BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 21837368)

  • 1. Inhibition of lymphoma cell proliferation by peroxisomal proliferator-activated receptor-γ ligands via Wnt signaling pathway.
    Liu JJ; Dai XJ; Xu Y; Liu PQ; Zhang Y; Liu XD; Fang ZG; Lin DJ; Xiao RZ; Huang RW; Huang HQ
    Cell Biochem Biophys; 2012 Jan; 62(1):19-27. PubMed ID: 21837368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating the balance between peroxisome proliferator-activated receptor gamma and beta-catenin signaling during adipogenesis. A glycogen synthase kinase 3beta phosphorylation-defective mutant of beta-catenin inhibits expression of a subset of adipogenic genes.
    Liu J; Farmer SR
    J Biol Chem; 2004 Oct; 279(43):45020-7. PubMed ID: 15308623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiazolidinediones Inhibit Mouse Osteoblastic MC3T3-E1 Cell Proliferation in Part Through the Wnt Signaling Pathway.
    Duan M; Zhou B; Zhou X; Yuan G
    J Investig Med; 2015 Jun; 63(5):758-64. PubMed ID: 25756249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk Between Peroxisome Proliferator-Activated Receptor Gamma and the Canonical WNT/β-Catenin Pathway in Chronic Inflammation and Oxidative Stress During Carcinogenesis.
    Vallée A; Lecarpentier Y
    Front Immunol; 2018; 9():745. PubMed ID: 29706964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GSK-3β suppresses the proliferation of rat hepatic oval cells through modulating Wnt/β-catenin signaling pathway.
    Ji XK; Xie YK; Zhong JQ; Xu QG; Zeng QQ; Wang Y; Zhang QY; Shan YF
    Acta Pharmacol Sin; 2015 Mar; 36(3):334-42. PubMed ID: 25661318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cytoplasmic GSK-3β increases cisplatin resistance through activation of Wnt/β-catenin signaling in A549/DDP cells.
    Gao Y; Liu Z; Zhang X; He J; Pan Y; Hao F; Xie L; Li Q; Qiu X; Wang E
    Cancer Lett; 2013 Aug; 336(1):231-9. PubMed ID: 23673211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Octreotide stimulates somatostatin receptor-induced apoptosis of SW480 colon cancer cells by activation of glycogen synthase kinase-3β, A Wnt/β-catenin pathway modulator.
    Wang S; Bao Z; Liang QM; Long JW; Xiao ZS; Jiang ZJ; Liu B; Yang J; Long ZX
    Hepatogastroenterology; 2013 Oct; 60(127):1639-46. PubMed ID: 24634935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. β-Catenin pathway is required for TGF-β1 inhibition of PPARγ expression in cultured hepatic stellate cells.
    Qian J; Niu M; Zhai X; Zhou Q; Zhou Y
    Pharmacol Res; 2012 Sep; 66(3):219-25. PubMed ID: 22706027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Reabroi S; Saeeng R; Boonmuen N; Kasemsuk T; Saengsawang W; Suksen K; Zhu W; Piyachaturawat P; Chairoungdua A
    Sci Rep; 2018 May; 8(1):7924. PubMed ID: 29784906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EZH2-mediated repression of GSK-3β and TP53 promotes Wnt/β-catenin signaling-dependent cell expansion in cervical carcinoma.
    Chen Q; Zheng PS; Yang WT
    Oncotarget; 2016 Jun; 7(24):36115-36129. PubMed ID: 27092879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of multidrug resistance by rosiglitazone treatment in human ovarian cancer cells through downregulation of FZD1 and MDR1 genes.
    Zhang H; Jing X; Wu X; Hu J; Zhang X; Wang X; Su P; Li W; Zhou G
    Anticancer Drugs; 2015 Aug; 26(7):706-15. PubMed ID: 26053275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer's disease.
    Vallée A; Lecarpentier Y; Guillevin R; Vallée JN
    Acta Biochim Biophys Sin (Shanghai); 2017 Oct; 49(10):853-866. PubMed ID: 28981597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO; Oh JH; Son SM; Won D; Song HS; Han SB; Moon DC; Kang KW; Song MJ; Hong JT
    Cancer Biol Ther; 2011 Aug; 12(4):288-96. PubMed ID: 21613824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of NF-kappaB and GSK-3beta is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone.
    Ban JO; Kwak DH; Oh JH; Park EJ; Cho MC; Song HS; Song MJ; Han SB; Moon DC; Kang KW; Hong JT
    Chem Biol Interact; 2010 Oct; 188(1):75-85. PubMed ID: 20540935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of β-catenin signaling suppresses pancreatic tumor growth by disrupting nuclear β-catenin/TCF-1 complex: critical role of STAT-3.
    Pramanik KC; Fofaria NM; Gupta P; Ranjan A; Kim SH; Srivastava SK
    Oncotarget; 2015 May; 6(13):11561-74. PubMed ID: 25869100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mechanism of hepatocellular carcinoma cell apoptosis induced by lupeol via Brain-Derived Neurotrophic Factor Inhibition and Glycogen Synthase Kinase 3 beta reactivation.
    Zhang L; Tu Y; He W; Peng Y; Qiu Z
    Eur J Pharmacol; 2015 Sep; 762():55-62. PubMed ID: 26004524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A silyl andrographolide analogue suppresses Wnt/β-catenin signaling pathway in colon cancer.
    Reabroi S; Chairoungdua A; Saeeng R; Kasemsuk T; Saengsawang W; Zhu W; Piyachaturawat P
    Biomed Pharmacother; 2018 May; 101():414-421. PubMed ID: 29501763
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via the Wnt/GSK-3β/β-catenin pathway.
    Sun J; Yan P; Chen Y; Chen Y; Yang J; Xu G; Mao H; Qiu Y
    Diagn Pathol; 2015 Jun; 10():72. PubMed ID: 26088648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FNC, a novel nucleoside analogue, blocks invasion of aggressive non-Hodgkin lymphoma cell lines via inhibition of the Wnt/β-catenin signaling pathway.
    Zhang Y; Wang CP; Ding XX; Wang N; Ma F; Jiang JH; Wang QD; Chang JB
    Asian Pac J Cancer Prev; 2014; 15(16):6829-35. PubMed ID: 25169533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.